These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34860243)

  • 1. Identifying Diagnostic MicroRNAs and Investigating Their Biological Implications in Rectal Cancer.
    Kim JK; Qu X; Chen CT; Smith JJ; Sanchez-Vega F; Garcia-Aguilar J
    JAMA Netw Open; 2021 Dec; 4(12):e2136913. PubMed ID: 34860243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer.
    Campayo M; Navarro A; Benítez JC; Santasusagna S; Ferrer C; Monzó M; Cirera L
    PLoS One; 2018; 13(11):e0206542. PubMed ID: 30388154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
    Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
    Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of tumor suppressor miRNAs by integrative miRNA and mRNA sequencing of matched tumor-normal samples in lung adenocarcinoma.
    Yu N; Yong S; Kim HK; Choi YL; Jung Y; Kim D; Seo J; Lee YE; Baek D; Lee J; Lee S; Lee JE; Kim J; Kim J; Lee S
    Mol Oncol; 2019 Jun; 13(6):1356-1368. PubMed ID: 30913346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
    Svoboda M; Sana J; Fabian P; Kocakova I; Gombosova J; Nekvindova J; Radova L; Vyzula R; Slaby O
    Radiat Oncol; 2012 Nov; 7():195. PubMed ID: 23167930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
    Sharma P; Saraya A; Sharma R
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microRNAs Identified by Small RNA Sequencing as Potential Response Predictors in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy.
    Machackova T; Trachtova K; Prochazka V; Grolich T; Farkasova M; Fiala L; Sefr R; Kiss I; Skrovina M; Dosoudil M; Berindan-Neagoe I; Svoboda M; Slaby O; Kala Z
    Cancer Genomics Proteomics; 2020; 17(3):249-257. PubMed ID: 32345666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
    Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
    Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of microRNA-199a-5p is associated with superior clinical outcomes in patients with locally advanced rectal cancer.
    Baek DW; Kim G; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Kang MK; Hur K; Kim JG
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):105-115. PubMed ID: 31781865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
    Lopes-Ramos CM; Habr-Gama A; Quevedo Bde S; Felício NM; Bettoni F; Koyama FC; Asprino PF; Galante PA; Gama-Rodrigues J; Camargo AA; Perez RO; Parmigiani RB
    BMC Med Genomics; 2014 Dec; 7():68. PubMed ID: 25496125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic approach introduced novel targets in rectal cancer by considering miRNA/mRNA interactions in response to radiotherapy.
    Khalighfard S; Kalhori MR; Amiriani T; Poorkhani A; Khori V; Esmati E; Lashkari M; Najafi A; Alizadeh AM
    Cancer Biomark; 2022; 33(1):97-110. PubMed ID: 34366323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer.
    Eriksen AH; Andersen RF; Pallisgaard N; Sørensen FB; Jakobsen A; Hansen TF
    PLoS One; 2016; 11(3):e0150593. PubMed ID: 26937645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rectal cancer microRNAome--microRNA expression in rectal cancer and matched normal mucosa.
    Gaedcke J; Grade M; Camps J; Søkilde R; Kaczkowski B; Schetter AJ; Difilippantonio MJ; Harris CC; Ghadimi BM; Møller S; Beissbarth T; Ried T; Litman T
    Clin Cancer Res; 2012 Sep; 18(18):4919-30. PubMed ID: 22850566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
    Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
    Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
    [No Abstract]   [Full Text] [Related]  

  • 16. Global analysis of miRNA-mRNA regulation pair in bladder cancer.
    Fan X; Zou X; Liu C; Peng S; Zhang S; Zhou X; Wang T; Zhu W
    World J Surg Oncol; 2022 Mar; 20(1):66. PubMed ID: 35241117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
    Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of recurrence-associated microRNAs in stage I lung adenocarcinoma.
    Sim J; Kim Y; Kim H; Shin SJ; Kim DH; Paik SS; Jang K
    Medicine (Baltimore); 2018 Jun; 97(25):e10996. PubMed ID: 29923982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
    Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
    Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in microRNA expression associated with alcohol consumption in rectal cancer subjects.
    Mullany LE; Herrick JS; Wolff RK; Stevens JR; Slattery ML
    Cancer Causes Control; 2017 Jun; 28(6):545-555. PubMed ID: 28303484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.